©The Author(s) 2026.
World J Diabetes. Jan 15, 2026; 17(1): 112027
Published online Jan 15, 2026. doi: 10.4239/wjd.v17.i1.112027
Published online Jan 15, 2026. doi: 10.4239/wjd.v17.i1.112027
Figure 8 Interaction between microtubule affinity-regulating kinase 4 and microtubule-associated protein 1 light chain 3B.
A: Several proteins that interact with microtubule affinity-regulating kinase 4; B: Co-immunoprecipitation verification of the interaction between microtubule affinity-regulating kinase 4 and microtubule-associated protein 1 light chain 3B in cardiomyocytes (n = 4). Results from triplicate experiments. MARK4: Microtubule affinity-regulating kinase 4; LC3B: Microtubule-associated protein 1 light chain 3B; IP: Immunoprecipitation.
- Citation: Wu Y, Wang WY, Zhang JQ, Wang S, Zeng Z, Fu L, Li B. Microtubule affinity-regulating kinase 4 exacerbates diabetic cardiomyopathy by inhibiting UNC-51-like kinase 1-mediated mitochondrial autophagy. World J Diabetes 2026; 17(1): 112027
- URL: https://www.wjgnet.com/1948-9358/full/v17/i1/112027.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i1.112027